Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 23, 2024Cell Communication and SignalingOpen Access

Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib)

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMagdalena KotASAleksandra SimiczyjewJWJustyna Wądzyńska

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kot et al. (2024) studied this question.

synapsesocial.com/papers/68e5b288b6db64358754bab3https://doi.org/10.1186/s12964-024-01788-3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phenotype switching in highly invasive resistant to vemurafenib and cobimetinib melanoma cells2025 · 5 citations
  2. 2Comprehensive transcriptomic characterization of two melanoma cell lines with acquired dual resistance to BRAF and MEK inhibitors2026 · 2 citations
  3. 3Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells2026
  4. 4Abstract 5847: Characterizing mechanisms of BRAF/MEK inhibitor resistance in BRAF V600 mutant colorectal cancer vs. melanoma2024
  5. 5Abstract 5869: Investigation of molecular alterations associated with double resistance to BRAF and MEK inhibition in melanoma2024